Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer

Overview of attention for article published in Oncotarget, January 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#28 of 12,118)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Dimensions has found 3 publications that cite this research output.

Article in Radiation Oncology (March 2019)

Article in Journal of Chinese Physician (March 2019)

Article in Expert Review of Anticancer Therapy (September 2018)